Abstract:The sodium (Na ) leak channel (NALCN) is a member of the four-domain voltage-gated cation channel family that includes the prototypical voltage-gated sodium and calcium channels (Na s and Ca s, respectively). Unlike Na s and Ca s, which have four lateral fenestrations that serve as routes for lipophilic compounds to enter the central cavity to modulate channel function, NALCN has bulky residues (W311, L588, M1145 and Y1436) that block these openings. Structural data suggest that oc-cluded lateral fenestrations underlie the pharmacological resistance of NALCN to lipophilic compounds, but functional evidence is lacking. To test this hypothesis, we unplugged the fenestrations of NALCN by substituting the four aforementioned resi-dues with alanine (AAAA) and compared the effects of Na , Ca and NALCN block-ers on both wild-type (WT) and AAAA channels. Most compounds behaved in a simi-lar manner on both channels, but phenytoin and 2-aminoethoxydiphenyl borate (2-APB) elicited additional, distinct responses on AAAA channels. Further experiments using single alanine mutants revealed that phenytoin and 2-APB enter the inner cav-ity through distinct fenestrations, implying structural specificity to their modes of ac-cess. Using a combination of computational and functional approaches, we identified amino acid residues critical for 2-APB activity, supporting the existence of drug bind-ing site(s) within the pore region. Intrigued by the activity of 2-APB and its ana-logues, we tested additional compounds containing the diphenylmethane/amine moiety on WT channels. We identified compounds from existing clinically used drugs that exhibited diverse activity, thus expanding the pharmacological toolbox for NALCN. While the low potencies of active compounds reiterate the resistance of NALCN to pharmacological targeting, our findings lay the foundation for rational drug design to develop NALCN modulators with refined properties.

Structure of the Human Sodium Leak Channel NALCN in Complex with FAM155A

Structure of voltage-modulated sodium-selective NALCN-FAM155A channel complex

Structure and mechanism of NALCN-FAM155A-UNC79-UNC80 channel complex

Structural mechanism of voltage-gated sodium channel slow inactivation.

Structure of the Human Voltage-Gated Sodium Channel Nav1.4 in Complex with Β1.

The neuronal channel NALCN contributes resting sodium permeability and is required for normal respiratory rhythm.

The sodium leak channel NALCN is regulated by neuronal SNARE complex proteins

Cryo-EM structure of human voltage-gated sodium channel Na <sub>v</sub> 1.6

Cryo-EM structure of the human NKCC1 transporter reveals mechanisms of ion coupling and specificity

Cryo-EM structure of human voltage-gated sodium channel Nav1.6

Cryo-EM Structure of the Human Sodium-Chloride Cotransporter NCC

Role of sodium leak channel (NALCN) in sensation and pain: an overview

Cryo-EM Structure of the Calcium Homeostasis Modulator 1 Channel.

Structure of a eukaryotic voltage-gated sodium channel at near-atomic resolution

An all-atom model of the human cardiac sodium channel in a lipid bilayer

Epilepsy-associated Mutations in the Calcium-sensing Receptor Disrupt the Regulation of NALCN Sodium-leak Channel by Extracellular Calcium in Neurons

Unplugging lateral fenestrations of NALCN reveals a hidden drug binding site within the pore module

Dissection of the Structure-Function Relationship of Nav Channels

Comparative structural analysis of human Na<sub>v</sub>1.1 and Na<sub>v</sub>1.5 reveals mutational hotspots for sodium channelopathies

Gating mechanism of human N-type voltage-gated calcium channel

Unplugging lateral fenestrations of NALCN reveals a hidden drug binding site within the pore region